Glenmark Life Sciences' Stock Price Rises by 5.54% on Strong Performance and Diverse Portfolio
Glenmark Life Sciences, a midcap pharmaceutical company, saw a 5.54% increase in its stock price on October 8th, 2024. The company has a strong presence in domestic and international markets, with a diverse portfolio of affordable generic drugs. Its consistent performance and strong financials make it a promising investment option in the pharmaceutical industry.
Glenmark Life Sciences, a midcap pharmaceutical company, saw a rise in its stock price by 5.54% on October 8th, 2024. The stock was given a 'Hold' call by MarketsMOJO, a leading financial analysis platform.
The stock outperformed the sector by 4.17% and touched an intraday high of Rs 1199.95, a 5.64% increase. Glenmark Life Sciences is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In comparison to the Sensex, Glenmark Life Sciences had a 1-day performance of 5.37% while the Sensex only had a 0.60% performance. Over the past month, Glenmark Life Sciences has seen a 4.11% increase in its stock price, while the Sensex only had a 0.43% increase.
Glenmark Life Sciences is a midcap pharmaceutical company that focuses on developing and manufacturing high-quality, affordable generic drugs. The company has a strong presence in both domestic and international markets, with a diverse portfolio of products.
This recent increase in stock price could be attributed to the company's consistent performance and strong financials. Glenmark Life Sciences has been able to maintain a steady growth rate, making it a promising investment option in the pharmaceutical industry. With its focus on providing affordable healthcare solutions, the company is well-positioned for future growth and success.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
